KPCM
OGN icon

Kings Point Capital Management’s Organon & Co OGN Stock Holding History

Kings Point Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$21K Sell
610
-318
-34% -$10.9K ﹤0.01% 473
2021
Q4 		$28K Hold
928
– – ﹤0.01% 477
2021
Q3 		$30K Sell
928
-40
-4% -$1.28K ﹤0.01% 435
2021
Q2 		$29K Buy
+968
New +$31.9K ﹤0.01% 417

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kings Point Capital Management's OGN Position: Q1 2022 in Review

Kings Point Capital Management reduced its Organon & Co (OGN) stake by 34% in Q1 2022, selling an estimated $10.9K and leaving 610 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

Kings Point Capital Management first reported a position in OGN in Q2 2021 and has held it in 4 quarters since. The position peaked at $30K in Q3 2021. 819 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

  • Kings Point Capital Management held 610 shares of Organon & Co worth $21K as of Q1 2022.
  • Kings Point Capital Management sold 318 Organon & Co shares in Q1 2022, an estimated $10.9K.
  • Organon & Co made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #473 holding.
  • Kings Point Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 4 quarters since.
  • Kings Point Capital Management's Organon & Co position peaked at $30K in Q3 2021.
  • 819 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.